News about Global Pharma

Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device

The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.

Global Pharma | 08/02/2024 | By Manvi |  1456

Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring

This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.

Global Pharma | 08/02/2024 | By Manvi |  1171

Thermax Acquires TSA Process Equipments

Thermax has signed definitive agreements for acquisition to be completed in due course and will fully acquire the balance stake of the company over the next two years.

Global Pharma | 07/02/2024 | By Manvi |  898

AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD

The site, strategically located within Maryland's flourishing life sciences corridor and near universities, underscores AstraZeneca's commitment to innovation and talent recruitment.

Global Pharma | 07/02/2024 | By Manvi |  472

Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion

The companies anticipate completing the transaction in the coming months, subject to the satisfaction of closing conditions.

Global Pharma | 07/02/2024 | By Manvi |  654

Brenntag Specialties and KRONOS Extend Agreement for Pharma and Beauty & Personal Care Customers in EMEA

The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.

Global Pharma | 06/02/2024 | By Manvi |  318

Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands

The acquisition covers Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, and Thailand through its wholly-owned subsidiary, Zanovex Pte. Ltd.

Global Pharma | 05/02/2024 | By Manvi |  2074

Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million

The agreement encompasses Eugia's related assets, liabilities, and employees, as the company strategically focuses on enhancing capacities and operations in other units.

Global Pharma | 05/02/2024 | By Manvi |  1350

Gericke Announces Inauguration of its New Production Hall in Switzerland

The state-of-the-art facility marks a significant milestone in the company's commitment to meeting the growing demand for leading-edge technology in the powder processing industry.

Global Pharma | 03/02/2024 | By Manvi |  503

Biosyngen's BST02 Receives Fast Track Designation for Liver Cancer Treatment

Fast Track Designation is a special process designed to facilitate the development and expedite the review of drugs intended to treat serious or life-threatening conditions, addressing unmet medical needs.

Global Pharma | 03/02/2024 | By Manvi |  447